PRMT6 and tuberculosis: Qiang et al. [76] found tuberculosis (TB) treatment via blocking Mycobacterium tuberculosis (Mtb) protein tyrosine phosphatase A -host protein arginine methyltransferase 6 interface to target GPX4-dependent ferroptosis, eventually inducing ferroptosis to promote Mtb pathogenicity and dissemination.